Streetbeat News

Stock Prices

HRTX

Heron Therapeutics' stock is up following the FDA's approval of its supplemental NDA for ZYNRELEF, expanding its use to more orthopedic and soft tissue procedures.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:39 pm

SYF

Piper Sandler analyst Kevin Barker has maintained an Overweight rating on Synchrony Financial (NYSE:SYF) and increased the price target from $46 to $48.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:39 pm

STR

Piper Sandler analyst Mark Lear has maintained an Overweight rating on Sitio Royalties (NYSE:STR) but has reduced the price target from $31 to $26. This adjustment reflects a more conservative valuation of STR's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:37 pm

BMY

GILD

JNJ

NVS

The FDA has announced a classwide black box warning for all CAR-T therapies due to the risk of secondary T-cell cancers. Gilead Sciences Inc's Tecartus was initially included but has since been removed from the list requiring the warning. The FDA is considering further regulatory action based on clinical testing and safety monitoring reports. Other CAR-T therapies from Bristol Myers Squibb, Novartis AG, and Johnson & Johnson/Legend Biotech Corporation are still required to carry the warning. Gilead's stock price has seen a slight decline following the news.

Portfolio Pulse from Vandana Singh

January 24, 2024 | 3:36 pm

Piper Sandler analyst Mark Lear has maintained an Overweight rating on Permian Resources (NYSE:PR) but has reduced the price target from $19 to $17. This adjustment reflects a change in valuation but continues to suggest a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:35 pm

Trading for an IPO security was halted and then resumed for quotation at 10:35 AM ET. The specific security is not named, but there is a hint that it may be related to 'JL'.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:35 pm

AAPL

AMD

AMZN

EBAY

GBTC

GOOGL

LMT

NFLX

TSLA

TXN

Cryptocurrencies like Bitcoin, Ethereum, and Dogecoin are in the red, with Grayscale Bitcoin Trust (GBTC) continuing to bleed. Netflix hints at future price hikes. Texas Instruments reported Q4 results alongside other stocks moving lower in pre-market. US and world politics feature Trump and Biden's remarks, Turkey's NATO move, and North Korea's missile tests. China urges hedge funds to limit short selling. Tech companies like eBay, AMD, ASML, SAP, Amazon, Apple, and Alphabet see various developments. Electric vehicle news includes Tesla's upcoming earnings and job openings, Polestar, and Ford's USPS fleet. Netflix may raise prices and is praised for Q4 results. Lockheed Martin and Boeing face challenges in the industrial sector.

Portfolio Pulse from Akanksha Bakshi

January 24, 2024 | 3:32 pm

KURA

Kura Oncology's stock is trading higher following the announcement of a successful $150 million private placement, indicating strong investor interest and financial backing for the company.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:32 pm

KMB

Kimberly-Clark Corp (NYSE:KMB) shares dropped after reporting Q4 FY23 results with flat sales of $4.97 billion, missing estimates by $0.01 billion. Organic sales grew by 3%, but adjusted EPS of $1.51 missed expectations by $0.03. Gross margin improved, but operating income declined by 6%. The company completed $225 million in share repurchases and holds $1.09 billion in cash. The 2024 outlook includes low-to-mid single digit organic net sales growth, with currency and divestiture impacts. Shares fell 4.57% to $119.24.

Portfolio Pulse from Lekha Gupta

January 24, 2024 | 3:31 pm

SMBK

Keefe, Bruyette & Woods analyst Catherine Mealor has maintained a 'Market Perform' rating on SmartFinancial (NYSE:SMBK) and increased the price target from $25 to $26.

Portfolio Pulse from Benzinga Newsdesk

January 24, 2024 | 3:31 pm